Outset Medical (OM) has received a new Buy rating, initiated by BTIG analyst, Marie Thibault. Marie Thibault’s rating is based on a variety of positive indicators for Outset Medical, despite some ...

Columbia Acorn Fund, distributed by Columbia Management Investment Distributors, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the quarter, the fund ...

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, ...

Secures New Debt Financing of up to $125M Maturing in 2030 with Plans to Retire $200M in Prior Debt In addition, Outset has entered into a credit agreement and guaranty with a fund managed by ...

Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener The latest update ...

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Outset Medical, Inc.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The recalls are related to FDA concerns about a toxic ...

Outset said that it has resumed distribution of TabloCart with prefiltration and has product available to ship to customers in the United States. “With the FDA’s clearance of TabloCart with ...

Revenue for 2025 is projected to be between $115 million and $125 million, with expectations of console growth and recurring revenue expansion. Gross margins for 2025 are expected to be in the high 30 ...